ARRIVENT BIOPHARMA INC (AVBP) Stock Balance Sheet
NASDAQ:AVBP - Nasdaq - US04272N1028 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 49.87M | 74.29M | 150.39M | 163.37M | 37.28M | |||
| Marketable Securities | 126.21M | 144.57M | N/A | N/A | N/A | |||
| Receivables | 505.00K | 500.00K | 761.00K | 500.00K | 250.00K | |||
| Other Current Assets | 9.20M | 7.62M | 8.82M | 18.75M | 5.42M | |||
| Total Current Assets | 185.78M | 226.98M | 159.97M | 182.62M | 42.95M | |||
| Non-Current Assets | ||||||||
| PPE Net | 120.00K | 154.00K | 291.00K | 139.00K | 0.00 | |||
| Investments And Advances | 29.41M | 47.68M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 176.00K | 126.00K | 2.84M | 72.00K | 87.00K | |||
| Total Non-Current Assets | 29.71M | 47.96M | 3.13M | 211.00K | 87.00K | |||
| TOTAL ASSETS | 215.50M | 274.94M | 163.10M | 182.83M | 43.04M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 8.59M | 13.49M | 7.09M | 5.27M | 1.52M | |||
| Accounts Payable | 4.36M | 3.78M | 4.53M | 3.09M | 293.00K | |||
| Total Current Liabilities | 12.95M | 17.27M | 11.62M | 8.36M | 1.82M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 14.00K | 177.00K | 11.00K | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 14.00K | 177.00K | 11.00K | 0.00 | |||
| TOTAL LIABILITIES | 12.95M | 17.29M | 11.80M | 8.37M | 1.82M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -302.72M | -238.33M | -157.84M | -88.51M | -51.61M | |||
| Additional Paid In Capital | 505.27M | 496.19M | 4.65M | 3.40M | 2.96M | |||
| Common Shares | 4.00K | 3.00K | 304.49M | 259.57M | 89.86M | |||
| Other Shareholders' Equity | -17.00K | -211.00K | 0.00 | 0.00 | -2.00K | |||
| Shares Outstanding | 34.04M | 33.71M | 31.96M | 31.96M | 31.96M | |||
| Tangible Book Value per Share | 5.95 | 7.64 | -4.79 | -2.66 | -1.52 | |||
| Total Shareholders' Equity | 202.54M | 257.65M | 151.30M | 174.46M | 41.22M | |||
| TOTAL LIABILITIES AND EQUITY | 215.50M | 274.94M | 163.10M | 182.83M | 43.04M | |||
| Statistics | ||||||||
| Current Ratio | 14.34 | 13.14 | 13.76 | 21.84 | 23.63 | |||
| Return On Assets (ROA) | -59.15% | -29.27% | -42.51% | -20.19% | -119.91% | |||
| Return On Equity (ROE) | -62.93% | -31.24% | -45.83% | -21.15% | -125.19% | |||
All data in USD , ROIC based on taxRate of 0.21